ライフサイエンスコーパス: heliox

1 thy score improved significantly faster with heliox.

2 lower oscillation amplitude is required with heliox.

3 volume delivery was significantly less with heliox.

4 frame and during identical treatment without HELIOX.

5 es were done on more specific issues such as heliox.

6 10% [7% to 13%], AIR + 9% [5% to 13%]; 2 hr HELIOX + 10% [6% to 15%], AIR + 10% [6% to 14%]).

7 by either the 1 hr or 2 hr time point (1 hr, HELIOX + 10% [7% to 13%], AIR + 9% [5% to 13%]; 2 hr HEL

8 re rate (NIV failure: air/O2 14.5% [n = 32]; heliox 14.7% [n = 33]; P = 0.97, and time to NIV failure

9 n the AIR group at both the 1 hr time point (HELIOX + 14% [7% to 22%] vs. AIR + 7% [3% to 10%], p = .

10 o 10%], p = .05) and at the 2 hr time point (HELIOX + 15% [8% to 21%] vs. AIR + 7% [4% to 11%], p = .

11 Three patients (1 HELIOX, 2 AIR) were unable to complete the study.

12 oxygen-enriched air (60% O(2)/40% N(2)) and heliox (60% O(2)/ 40% He and 40% O(2)/60% He).

13 were constructed using 100 strokes each for heliox (70:30 mixture), NO, and perfluorocarbon.

14 The clinical benefit of heliox administration during high-frequency oscillatory

15 Both heliox and bilevel positive pressure ventilation have de

16 At baseline, the HELIOX and control groups had similar (A-a)gradients (21

17 difference in Paco(2) or Pao(2) between the heliox and oxygen-enriched air with either the 40% or 60

18 Use of HELIOX as a driving gas for the updraft nebulization of

19 ver, the SV300 delivered 7.9% less volume of heliox at a set tidal volume of 500 mL and 10.8% less at

20 When challenged to fly in low-density heliox, bees responded by maintaining nearly constant wi

21 , negative-pressure (iron-lung) ventilation, heliox breathing, and inspiratory resistive loading.

22 A 70:30 mixture of heliox caused a significantly overestimated gas volume m

23 Heliox decreased the conductance of the pneumotachometer

24 However, heliox did not affect its linearity.

25 Heliox did not affect volumes delivered with the S900C v

26 idal volume delivery is maintained constant, heliox does not alter gas exchange when compared with ox

27 when tidal volume delivery is held constant, heliox does not alter gas exchange.

28 rometric effects of albuterol nebulized with heliox during emergency room visits for asthma exacerbat

29 termine whether continuous administration of heliox for 72 hours, during and in-between NIV sessions,

30 red gases of room air and a 70:30 mixture of heliox from the above ventilators were collected into a

31 Novel therapies, such as a heliox gaseous mixture and noninvasive bilevel positive

32 14.6% in the control group and 32.4% in the heliox group (p = 0.007).

33 [n = 33]; P = 0.97, and time to NIV failure: heliox group 93 hours [n = 33], air/O2 group 52 hours [n

34 ce interval, 35% to 52%) of predicted in the HELIOX group and 39 (31% to 46%) of predicted in the AIR

35 The reduction in (A-a)gradient in the HELIOX group facilitated a reduction in F(IO)2 from 0.8+

36 The heliox group had a significantly higher heart rate after

37 e no adverse outcomes observed in either the HELIOX group or the AIR group.

38 in FEF25-75 was significantly greater in the HELIOX group than in the AIR group at both the 1 hr time

39 ents intubated after NIV failed, patients on heliox had a shorter ventilation duration (7.4 +/- 7.6 d

40 Heliox had no affect on volumes delivered by the S900C.

41 Because heliox has a lower density as compared with air, we post

42 Although heliox improved gas exchange during HFOV in our model, i

43 MV with HELIOX improves (A-a)gradient in patients with SA.

44 mography measurements, we also conclude that heliox improves carbon dioxide elimination primarily thr

45 Heliox improves lung deposition of inhaled particles whe

46 Heliox improves respiratory acidosis, encephalopathy, an

47 A total of 11 patients receiving HELIOX in the first 2 hrs of MV for SA were compared wit

48 Possible advantages of heliox include improved ventilation of larger patients w

49 thma exacerbations, albuterol nebulized with heliox leads to a more significant improvement in spirom

50 Heliox might prevent intubation or improve gas flow in m

51 terol nebulized with oxygen (control) versus heliox (n = 22 control and 23 heliox subjects).

52 ncentration and thus permit full benefits of HELIOX on lung mechanics to be realized in even the most

53 e prospectively randomized to receive either HELIOX or AIR as the driving gas for updraft nebulizatio

54 Use of HELIOX or standard nitrogen-oxygen mixtures during MV.

55 pinephrine, steroids, helium-oxygen therapy (heliox), or noninvasive positive pressure ventilation wi

56 44 torr after initiation of ventilation with HELIOX (p < .0003), whereas it did not change significan

57 disease (COPD) exacerbations, helium/oxygen (heliox) reduces the work of breathing and hypercapnia mo

58 ometers in critically ill children receiving heliox requires recalibration.

59 We conclude that heliox significantly improves carbon dioxide elimination

60 ontrol) versus heliox (n = 22 control and 23 heliox subjects).

61 with the SV300 were significantly reduced by heliox, the difference can be corrected easily by increa

62 us asthmaticus (SA) in patients who received HELIOX with those who did not.

63 ity as compared with air, we postulated that heliox would improve gas exchange during high-frequency